This biotinylated SARS-CoV-2 Spike RBD protein is expressed in human 293 (HEK293) cells and contains the receptor-binding domain (AA Arg 319-Lys 537) of the spike glycoprotein. It features a C-terminal polyhistidine tag followed by an Avitag™, which is enzymatically labeled with biotin. This protein is designed for applications in antibody and T-cell response studies, as well as binding assays for ACE2 receptors. The protein is supplied in a lyophilized state and validated via SDS-PAGE and SEC-MALS.
- Greater than 95% purity as determined by SDS-PAGE
- Greater than 90% purity as determined by SEC-MALS
- Endotoxin level of less than 1.0 EU per μg
- Calculated molecular weight of 28.2 kDa
- Formulated in PBS, pH 7.4 with trehalose as a protectant
- Verified binding activity to human ACE2 and neutralizing antibodies